96 related articles for article (PubMed ID: 23820930)
1. Case-control analysis on metformin and cancer of the esophagus.
Becker C; Meier CR; Jick SS; Bodmer M
Cancer Causes Control; 2013 Oct; 24(10):1763-70. PubMed ID: 23820930
[TBL] [Abstract][Full Text] [Related]
2. Metformin and the risk of endometrial cancer: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Gynecol Oncol; 2013 Jun; 129(3):565-9. PubMed ID: 23523618
[TBL] [Abstract][Full Text] [Related]
3. Metformin and the risk of head and neck cancer: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Diabetes Obes Metab; 2014 Nov; 16(11):1148-54. PubMed ID: 25041125
[TBL] [Abstract][Full Text] [Related]
4. Metformin does not alter the risk of lung cancer: a case-control analysis.
Bodmer M; Becker C; Jick SS; Meier CR
Lung Cancer; 2012 Nov; 78(2):133-7. PubMed ID: 22959242
[TBL] [Abstract][Full Text] [Related]
5. No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study.
Becker C; Jick SS; Meier CR; Bodmer M
BMC Cancer; 2015 Oct; 15():719. PubMed ID: 26475035
[TBL] [Abstract][Full Text] [Related]
6. Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis.
Bodmer M; Becker C; Meier C; Jick SS; Meier CR
Cancer Epidemiol Biomarkers Prev; 2012 Feb; 21(2):280-6. PubMed ID: 22178569
[TBL] [Abstract][Full Text] [Related]
7. Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis.
Bodmer M; Becker C; Meier C; Jick SS; Meier CR
Am J Gastroenterol; 2012 Apr; 107(4):620-6. PubMed ID: 22290402
[TBL] [Abstract][Full Text] [Related]
8. Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study.
Imfeld P; Bodmer M; Jick SS; Meier CR
J Am Geriatr Soc; 2012 May; 60(5):916-21. PubMed ID: 22458300
[TBL] [Abstract][Full Text] [Related]
9. Use of metformin and the risk of ovarian cancer: a case-control analysis.
Bodmer M; Becker C; Meier C; Jick SS; Meier CR
Gynecol Oncol; 2011 Nov; 123(2):200-4. PubMed ID: 21802715
[TBL] [Abstract][Full Text] [Related]
10. Metformin and the risk of renal cell carcinoma: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Eur J Cancer Prev; 2017 May; 26(3):257-262. PubMed ID: 26945286
[TBL] [Abstract][Full Text] [Related]
11. Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study.
Brauchli YB; Jick SS; Curtin F; Meier CR
J Am Acad Dermatol; 2008 Mar; 58(3):421-9. PubMed ID: 18194825
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
Azoulay L; Schneider-Lindner V; Dell'aniello S; Schiffrin A; Suissa S
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):335-42. PubMed ID: 20052677
[TBL] [Abstract][Full Text] [Related]
13. Metformin and the incidence of prostate cancer in patients with type 2 diabetes.
Azoulay L; Dell'Aniello S; Gagnon B; Pollak M; Suissa S
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):337-44. PubMed ID: 21148757
[TBL] [Abstract][Full Text] [Related]
14. Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus.
Qiu H; Rhoads GG; Berlin JA; Marcella SW; Demissie K
Diabetes Obes Metab; 2013 Apr; 15(4):349-57. PubMed ID: 23137378
[TBL] [Abstract][Full Text] [Related]
15. Metformin use and the risk of esophageal cancer in Barrett esophagus.
Agrawal S; Patel P; Agrawal A; Makhijani N; Markert R; Deidrich W
South Med J; 2014 Dec; 107(12):774-9. PubMed ID: 25502158
[TBL] [Abstract][Full Text] [Related]
16. Diabetes, use of antidiabetic drugs, and the risk of glioma.
Seliger C; Ricci C; Meier CR; Bodmer M; Jick SS; Bogdahn U; Hau P; Leitzmann MF
Neuro Oncol; 2016 Mar; 18(3):340-9. PubMed ID: 26093337
[TBL] [Abstract][Full Text] [Related]
17. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK--a nested case-control analysis.
Bruderer SG; Bodmer M; Jick SS; Bader G; Schlienger RG; Meier CR
Diabetes Obes Metab; 2014 Sep; 16(9):801-11. PubMed ID: 24612200
[TBL] [Abstract][Full Text] [Related]
18. Metformin use and prostate cancer risk.
Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
[TBL] [Abstract][Full Text] [Related]
19. Metformin use and survival from lung cancer: A population-based cohort study.
Menamin ÚC; Cardwell CR; Hughes CM; Murray LM
Lung Cancer; 2016 Apr; 94():35-9. PubMed ID: 26973204
[TBL] [Abstract][Full Text] [Related]
20. Poorly controlled type 2 diabetes mellitus is associated with a decreased risk of incident gout: a population-based case-control study.
Bruderer SG; Bodmer M; Jick SS; Meier CR
Ann Rheum Dis; 2015 Sep; 74(9):1651-8. PubMed ID: 24728333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
